Bleeding Risk With Rivaroxaban vs Vitamin K Antagonists in Elderly Patients With Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Heart (British Cardiac Society)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bleeding Risk With Rivaroxaban Compared With Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation
Heart 2020 Dec 01;[EPub Ahead of Print], O Hanon, JS Vidal, G Pisica-Donose, G Orvoën, JP David, E Chaussade, L Caillard, LW de Jong, N Boulloche, U Vinsonneau, S Bouée, P Krolak-Salmon, L Fauchier, P Jouanny, G Sacco, F Bellarbre, J Belmin, F Puisieux, M Lilamand, E Paillaud, AS BoureauFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.